Anti-myelin-associated glycoprotein neuropathy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Opinion in Neurology

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.wco.0000245368.36576.0dPMID 16969155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unraveling the differential expression of the two isoforms of myelin-associated glycoprotein in a mouse expressing GFP-tagged S-MAG specifically regulated and targeted into the different myelin compartments.

  2006cited by this paper
• Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia.

  2006cited by this paper
• High-dose rituximab and anti-MAG–associated polyneuropathy

  2006cited by this paper
• Immunodetection of anti-MAG IgM antibody by cross-reactivity to LA-N-1 neuroblastoma cells.

  2005cited by this paper
• Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside.

  2005cited by this paper
• Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.

  2005cited by this paper
• Worsening after rituximab treatment in anti‐mag neuropathy

  2005cited by this paper
• IgM deposits on skin nerves in anti–myelin‐associated glycoprotein neuropathy

  2005cited by this paper
• Another tool for the neurologist's toolbox

  2005cited by this paper
• Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems.

  2003cited by this paper
• Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximab

  2003cited by this paper
• Treatment of IgM antibody associated polyneuropathies using rituximab

  2003cited by this paper
• Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy

  2003cited by this paper
• Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodies

  2003cited by this paper
• Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing.

  2002cited by this paper
• Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

  2002cited by this paper
• Cladribine in the treatment of IgM paraproteinemic polyneuropathy.

  2002cited by this paper
• Myelin‐associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases

  2002cited by this paper
• The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho

  2002cited by this paper
• Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies.

  2001cited by this paper
• Activité autoanticorps des IgM monoclonales vis-à-vis des glycoconjugués du nerf périphérique : à propos de 112 cas

  2001cited by this paper
• [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].

  2001cited by this paper
• Focal myelin swellings and tomacula in anti‐MAG IgM paraproteinaemic neuropathy: Novel teased nerve fiber studies

  2001cited by this paper
• Siglecs, sialic acids and innate immunity.

  2001cited by this paper
• The small myelin-associated glycoprotein binds to tubulin and microtubules.

  2001cited by this paper
• Microtubule-associated protein 1B

  2001cited by this paper
• Distal acquired demyelinating symmetric neuropathy

  2000cited by this paper
• Multiple functions of the myelin‐associated glycoprotein MAG (siglec‐4a) in formation and maintenance of myelin

  2000cited by this paper
• Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

  1999cited by this paper
• IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab

  1999cited by this paper
• Small‐fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases

  1998cited by this paper
• Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons

  1998cited by this paper
• Myelin-associated Glycoprotein Interacts with Neurons via a Sialic Acid Binding Site at ARG118 and a Distinct Neurite Inhibition Site

  1997cited by this paper
• Gene dosage effects in hereditary peripheral neuropathy

  1997cited by this paper
• Neuropathies associated with monoclonal gammopathies.

  1996cited by this paper
• Quantitation of epidermal nerves in diabetic neuropathy

  1996cited by this paper
• Crucial Role for the Myelin‐associated Glycoprotein in the Maintenance of Axon‐Myelin Integrity

  1995cited by this paper
• Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside.

  1994cited by this paper
• Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies

  1992cited by this paper
• Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres

  1989cited by this paper
• The spectrum of IgM monoclonal gammopathy in 430 cases.

  1987cited by this paper
• Demyeliating neuropathy and monoclonal IgM antibody to myelin‐associated glycoprotein

  1983cited by this paper
• Myelin‐Associated Glycoprotein Is the Antigen for a Monoclonal IgM in Polyneuropathy

  1982cited by this paper
• The diagnostic value of skin biopsies.

  1949cited by this paper

• Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS

  2025cites this paper
• Glycopolymer binds pathogenic IgM autoantibodies and pulls them into the mononuclear phagocyte system for degradation

  2025cites this paper
• Top 10 Clinical Pearls in Paraproteinemic Neuropathies

  2024cites this paper
• Monoclonal Gammopathy-Associated Neuropathy

  2024cites this paper
• Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management

  2024cites this paper
• Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy

  2023cites this paper
• IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protein peripheral neuropathies

  2023cites this paper
• Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis

  2022cites this paper
• Rare central nervous system lymphomas

  2022cites this paper
• Nerve ultrasound characteristics of immunoglobulin M neuropathy associated with anti‐myelin‐associated glycoprotein antibodies

  2022cites this paper
• Paraproteinemia and neuropathy

  2021cites this paper
• Neuropathies périphériques associées aux syndromes lymphoprolifératifs : spectre clinique et démarche diagnostique

  2021cites this paper
• Emerging glyco‐based strategies to steer immune responses

  2021cites this paper
• Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen‐specific glycopolymer

  2020cites this paper
• Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies.

  2020cites this paper
• Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India

  2020cites this paper
• CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell targeted therapies.

  2020cites this paper
• Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels.

  2018cites this paper
• A rare neurological complication of Waldenstrom's Macroglobulinemia.

  2018cites this paper
• Chronisch-immunvermittelte Neuropathien – Diagnostik und Therapie

  2018cites this paper
• Patient With 2 Hematologic Malignancies Presenting as Neurolymphomatosis

  2018cites this paper
• Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies

  2018cites this paper
• High‐affinity heterotetramer formation between the large myelin‐associated glycoprotein and the dynein light chain DYNLL1

  2018cites this paper
• Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies

  2018cites this paper
• Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features

  2017cites this paper
• Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy

  2017cites this paper
• Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy

  2017cites this paper
• Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies

  2017cites this paper
• Paraproteinemic neuropathy

  2017cites this paper
• GSK249320, A Monoclonal Antibody Against the Axon Outgrowth Inhibition Molecule Myelin-Associated Glycoprotein, Improves Outcome of Rodents with Experimental Stroke

  2016cites this paper
• Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site

  2016cites this paper
• Ultrasound of the nerves - An appropriate addition to nerve conduction studies to differentiate paraproteinemic neuropathies.

  2016cites this paper
• Long‐term efficacy of rituximab in IgM anti‐myelin‐associated glycoprotein neuropathy: RIMAG follow‐up study

  2016cites this paper
• Eosinophil cationic protein (ECP) as a marker of eosinophil activation in autistic children: relation to autoimmunity

  2016cites this paper
• Immunological and Conformational characterization of synthetic peptide probes for autoimmune diseases

  2016cites this paper
• Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies

  2016influential citation
• Neuropathies sensitives

  2015cites this paper
• Unreliability of commercial anti‐MAG antibody and ganglioside assays

  2015influential citation
• Lymphoma-associated dysimmune polyneuropathies.

  2015cites this paper
• inding specificity of anti-HNK-1 IgM M-protein in anti-MAG europathy : Possible clinical relevance

  2015cites this paper
• Polyneuropathy associated with a monoclonal gammopathy

  2014cites this paper
• Immunology of Demyelinating Immune Neuropathies

  2014cites this paper
• THÈSE POUR LE DOCTORAT EN MÉDECINE

  2014cites this paper
• Paraneoplastic Neuromuscular Disorders

  2014cites this paper
• Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature

  2014cites this paper
• Antimyelin-Associated Glycoprotein, Antimyelin Basic Protein, and Antiproteolipid Autoantibodies in Neurologic Diseases

  2014cites this paper
• Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy.

  2014cites this paper
• Guidelines on the diagnosis and management of Waldenström macroglobulinaemia

  2014cites this paper
• Endogenous and Exogenous CD 1-Binding Glycolipids

  2014cites this paper
• Pleiotropic molecules in axon regeneration and neuroinflammation.

  2014cites this paper
• Pathophysiology of immune‐mediated demyelinating neuropathies—Part II: Neurology

  2013cites this paper
• Antibody testing in peripheral nerve disorders.

  2013cites this paper
• Immunoglobulin gene repertoire analysis during therapeutic B cell depletion

  2013cites this paper
• Neuropathies associées aux paraprotéinémies (gammapathies monoclonales)

  2013cites this paper
• FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2013cites this paper
• Lung cancer and paraneoplastic neurologic syndromes. Case report and review of the literature.

  2013cites this paper
• Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients

  2013cites this paper
• The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children.

  2013cites this paper
• [Relationship between vitamin D and autism spectrum disorder].

  2013cites this paper
• Anti-Myelin Associated Glycoprotein Polyneuropathy in a Patient With Lymphoma and its Resolution After Chemotherapy

  2013cites this paper
• Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity

  2012cites this paper
• Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.

  2012cites this paper
• [Neuropathies associated with monoclonal IgM anti-MAG antibodies].

  2012cites this paper
• Disorders of Peripheral Nerves

  2012cites this paper
• The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children.

  2012cites this paper
• Clinical and laboratory features of neuropathies with serum IgM binding to TS‐HDS

  2012cites this paper
• Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy.

  2012cites this paper
• Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy.

  2011cites this paper
• A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children

  2011cites this paper
• Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity

  2011cites this paper
• IgM monoclonal gammopathy–associated neuropathies with different IgM specificity

  2011cites this paper
• Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy

  2011cites this paper
• Occurrence and characterization of Pain in immune‐mediated neuropathies: a multicentre prospective study

  2011influential citation
• Auto-SCT in severe paraproteinemic neuropathy

  2011cites this paper
• Endogenous and Exogenous CD1-Binding Glycolipids

  2011cites this paper
• [Practical role of neuro-immunology in the diagnosis and management of peripheral neuropathies].

  2011cites this paper
• Neuropathy and paraproteins: review of a complex association

  2011cites this paper
• Peripheral Nerve and Skeletal Muscle

  2010cites this paper
• Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy

  2010cites this paper
• Morphological Progression of Myelin Abnormalities in IgM-Monoclonal Gammopathy of Undetermined Significance Anti-Myelin-Associated Glycoprotein Neuropathy

  2010cites this paper
• Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis

  2010cites this paper
• Cutaneous macroglobulinosis: a report of 2 cases.

  2010cites this paper
• Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy

  2010cites this paper
• Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia.

  2010cites this paper
• Anti-myelin-associated glycoprotein peripheral neuropathy as the only presentation of low grade lymphoma: a case report

  2009cites this paper
• Entrapment in anti myelin-associated glycoprotein neuropathy

  2009influential citation
• Immunoglobulin M Deposition in Cutaneous Nerves of Anti-Myelin-Associated Glycoprotein Polyneuropathy Patients Correlates With Axonal Degeneration

  2009cites this paper
• Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopy.

  2009cites this paper
• Dysimmune neuropathy.

  2009cites this paper
• Case 6-2008

  2009cites this paper
• Entrapment in anti myelin-associated glycoprotein neuropathy

  2009influential citation
• Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children.

  2008cites this paper
• Immunneuropathien - Von der Pathogenese zur Therapie

  2008cites this paper
• Regulation of axonal regeneration following the central nervous system injury in adult mammalian

  2008cites this paper
• B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.

  2008cites this paper
• Serum Anti-Myelin—Associated Glycoprotein Antibodies in Egyptian Autistic Children

  2008influential citation
• Prise en charge multidisciplinaire de la maladie de Waldenström ou macroglobulinémie

  2008cites this paper
• Autoantibodies in inflammatory demyelinating diseases of the central nervous system.

  2008cites this paper
• Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: Treatment update

  2008cites this paper
• Electrophysiology in demyelinating polyneuropathies

  2008cites this paper